Multiple sclerosis: Evidence of maternal effects and an increasing incidence in women

Neurology

Volumn 73, Issue 8, 2009, Pages 578-579

  Rose, John W ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY RESPONSE; ANTIBODY TITER; DISEASE TRANSMISSION; EDITORIAL; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; EXTRACHROMOSOMAL INHERITANCE; GENE INTERACTION; GENE LOCUS; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MORBIDITY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; WOMEN'S HEALTH;

EID: 69449104503     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181b529c6     Document Type: Editorial

References (15)

1. Butterfield R, Blankenhorn E, Roper R, et al. Genetic analysis of disease subtype and sexual dimorphism in mouse EAE: Relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J Immunol 1999;162:3096-3102.
2. DeJager P, Simon K, Munger K, Rioux J, Hafler D, Ascherio A. Integrating risk factors; HLA-DRβ1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 2008;70:1113-1118.
3. DeJager P, Jia X, Wang J, et al. A meta-analysis of genome scans and replication validate new MS susceptibility loci at TNFRSF1A, ICSBP1 and CD6. Nat Genet 2009 (in press).
4. Orton S, Herrera B, Yee I, et al, for the Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5:932-936.
5. Hirst C, Ingram G, Pickersgill T, Swingler R, Compston D, Robertson N. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009;80:386-391.
6. Hoppenbrouwers I, Liu F, Aulchenko Y, et al. Maternal transmission of multiple sclerosis in a Dutch population. Arch Neurol 2008;65:345-348.
7. Herrera B, Ramagopalan S, Lincoln M, et al. Parent of origin effects in MS: observations from avuncular pairs. Neurology 2008;71:799-803.
8. Willer C, Dyment D, Risch N, Sadovnick A, Ebers G, and the Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. PNAS 2003;100:12877-12882.
9. Willer C, Dyment D, Sadovnick A, Rothwell P, Murray TJ, Ebers G, and the Canadian Collaborative Study Group. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005;330:120.
10. Sadovnick A, Duquette P, Herrera B, Yee I, Ebers G. A timing-birth-effect on multiple sclerosis clinical phenotype. Neurology 2007;69:60-62. (Pubitemid 47025205)
11. Yasui Y, Hamajjima N, Nakamura T, El-Din N, Tajima K, Potter J. Association of Epstein-Barr virus antibody titers with a human IL-10 promoter polymorphism in Japanese women. J Autoimmune Dis 2008;5:2.
12. Hill K, Pigmans M, Fujinami R, Rose J. Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 or combined IL-4 with IL-10. J Neuroimmunol 1998;85:44-51. (Pubitemid 28255436)
13. Spach K, Hayes C. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005;175:4119-4126. (Pubitemid 41292076)
14. Spach K, Nashold F, Dittel F, Hayes C. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 2006;177:6030-6037. (Pubitemid 44628817)
15. Ramagopalan SV, Yee IM, Dyment DA, et al, for the Canadian Collaborative Study Group. Parent-of-origin effect in multiple sclerosis: observations from interracial matings. Neurology 2009;73:602-605.